Patents by Inventor George Paradissis

George Paradissis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090270503
    Abstract: The present disclosure relates to novel nutritional methods and compositions containing essential fatty acids which optimize embryonic, fetal and child neurological development and provides improved nutritional support for women prior to and during lactation. Further the methods and compositions improve gestational length and birth weight. The nutritional methods and compositions are also intended for use by women to optimize infant neurological development and provide improved nutritional support for women prior to, during and after lactation.
    Type: Application
    Filed: October 29, 2008
    Publication date: October 29, 2009
    Applicant: DRUGTECH CORPORATION
    Inventors: Marc S. Hermelin, R. Saul Levinson, George Paradissis
  • Patent number: 7112609
    Abstract: The present disclosure relates to novel nutritional methods and compositions containing essential fatty acids which optimize embryonic, fetal and child neurological development and provide improved nutritional support for women prior to and during lactation. Further the methods and compositions improve gestational length and birth weight. The nutritional methods and compositions are also intended for use by women to optimize infant neurological development and provide improved nutritional support for women prior to, during and after lactation.
    Type: Grant
    Filed: June 10, 2003
    Date of Patent: September 26, 2006
    Assignee: DrugTech Corporation
    Inventors: Marc S. Hermelin, R. Saul Levinson, George Paradissis
  • Publication number: 20050101670
    Abstract: The present disclosure relates to novel nutritional methods and compositions containing essential fatty acids which optimize embryonic, fetal and child neurological development and provide improved nutritional support for women prior to and during lactation. Further the methods and compositions improve gestational length and birth weight. The nutritional methods and compositions are also intended for use by women to optimize infant neurological development and provide improved nutritional support for women prior to, during and after lactation.
    Type: Application
    Filed: December 22, 2004
    Publication date: May 12, 2005
    Inventors: Marc Hermelin, R. Levinson, George Paradissis
  • Patent number: 6793935
    Abstract: The present invention is directed to a novel flavored extended release composition which forms a non-effervescent suspension when dropped into a liquid, and the methods of using said supplement, thereby minimizing and eliminating gastric discomfort. This flavored extended release composition provides the additional benefits of palatable taste and pleasant appearance.
    Type: Grant
    Filed: February 25, 2002
    Date of Patent: September 21, 2004
    Assignee: KV Pharmaceutical Company
    Inventors: Marc S. Hermelin, George Paradissis, James A. Garegnani
  • Publication number: 20030108605
    Abstract: The present invention is directed to a novel flavored extended release composition which forms a non-effervescent suspension when dropped into a liquid, and the methods of using said supplement, thereby minimizing and eliminating gastric discomfort. This flavored extended release composition provides the additional benefits of palatable taste and pleasant appearance.
    Type: Application
    Filed: December 30, 2002
    Publication date: June 12, 2003
    Applicant: KV Pharmaceutical Company
    Inventors: Marc S. Hermelin, George Paradissis, James A. Garegnani
  • Patent number: 6576666
    Abstract: The present disclosure relates to novel nutritional compositions containing linoleic acid and/or linolenic acid which optimize child neurological development and provide improved nutritional support for women prior to and during lactation. The nutritional compositions are intended for use by women to optimize infant neurological development and provide improved nutritional support for women prior to, during and after lactation.
    Type: Grant
    Filed: June 21, 2001
    Date of Patent: June 10, 2003
    Assignee: Drugtech Corporation
    Inventors: Marc S. Hermelin, R. Saul Levinson, George Paradissis
  • Publication number: 20020119183
    Abstract: The present invention is directed to a novel flavored extended release composition which forms a non-effervescent suspension when dropped into a liquid, and the methods of using said supplement, thereby minimizing and eliminating gastric discomfort. This flavored extended release composition provides the additional benefits of palatable taste and pleasant appearance.
    Type: Application
    Filed: February 25, 2002
    Publication date: August 29, 2002
    Applicant: KV Pharmaceutical Co.
    Inventors: Marc S. Hermelin, George Paradissis, James A. Garegnani
  • Publication number: 20020032234
    Abstract: The present disclosure relates to novel nutritional compositions containing linoleic acid and/or linolenic acid which optimize child neurological development and provide improved nutritional support for women prior to and during lactation. The nutritional compositions are intended for use by women to optimize infant neurological development and provide improved nutritional support for women prior to, during and after lactation.
    Type: Application
    Filed: June 21, 2001
    Publication date: March 14, 2002
    Applicant: DRUGTECH CORPORATION
    Inventors: Marc S. Hermelin, R. Saul Levinson, George Paradissis
  • Patent number: 6261600
    Abstract: The present invention is directed to novel chewable or dissolvable nutritional supplements for improving the absorption of folic acid in humans and other animals and methods of using said supplements. The nutritional supplements contain folic acid and non-toxic acid neutralizing alkaline compounds in chewable or dissolvable forms.
    Type: Grant
    Filed: April 30, 1999
    Date of Patent: July 17, 2001
    Assignee: DrugTech Corporation
    Inventors: Mitchell I. Kirschner, George Paradissis, R. Saul Levinson
  • Patent number: 6258846
    Abstract: The present disclosure relates to novel nutritional compositions containing linoleic acid and/or linolenic acid which optimize child neurological development and provide improved nutritional support for women prior to and during lactation. The nutritional compositions are intended for use by women to optimize infant neurological development and provide improved nutritional support for women prior to, during and after lactation.
    Type: Grant
    Filed: June 1, 1999
    Date of Patent: July 10, 2001
    Assignee: Drugtech Corporation
    Inventors: Marc S. Hermelin, R. Saul Levinson, George Paradissis
  • Patent number: 6228388
    Abstract: Multi-vitamin and mineral supplements for administration to a pregnant woman during her first, second, and third trimesters of pregnancy comprising specific regimens of a pharmaceutically acceptable calcium compound, vitamin D, folic acid, vitamin B12, vitamin B6, and vitamin B1. The prenatal supplements are specifically tailored to maximize fetal development and maternal health during each trimester of pregnancy.
    Type: Grant
    Filed: May 7, 1997
    Date of Patent: May 8, 2001
    Assignee: DrugTech Corporation
    Inventors: George Paradissis, R. Saul Levinson, Gary Heeter, Robert Cuca, Mitchell I. Kirschner
  • Patent number: 5494678
    Abstract: Multi-vitamin and mineral supplements for administration to a pregnant woman during her first, second, and third trimesters of pregnancy comprising specific regimens of a pharmaceutically acceptable calcium compound, vitamin D, folic acid, vitamin B.sub.12, vitamin B.sub.6, and vitamin B.sub.1. The prenatal supplements are specifically tailored to maximize fetal development and maternal health during each trimester of pregnancy.
    Type: Grant
    Filed: March 27, 1995
    Date of Patent: February 27, 1996
    Assignee: KV Pharmaceutical Corporation
    Inventors: George Paradissis, R. Saul Levinson, Gary Heeter, Robert Cuca, Mitchell I. Kirschner